Total expenses rose 11.79% to Rs 2342.52 crore in Q2 FY26 compared with Rs 2095.41 crore posted in corresponding quarter last year. Cost of material consumed stood at Rs 660.85 crore (up 13.11% YoY), employee benefit expenses was at Rs 32.11 crore (up 6.04% YoY), finance cost stood at Rs 49.28 crore (up 23.48% YoY) during the quarter.
In Q2 FY26, revenue from Bio Fuel segment stood at Rs 422.81 crore, up 62.89% YoY, revenue from potable spirits jumped 14.04% YoY to Rs 1,657.82 crore,. However, the Ennature Biopharma segment reported a decline of 28.73% YoY to Rs 43.44 crore and revenue from bio-based specialties and performance chemicals business dropped 21.95% YoY to Rs 288.33 crore.
India Glycols (IGL) manufactures green technology-based bulk, specialty and performance chemicals and natural gums, spirits, industrial gases, sugar and nutraceuticals. IGL operates under three broad segments: bio-based specialities & performance chemicals (BSPC), potable spirits (PS) and ennature biopharma (EB).
The scrip touched an all-time high at Rs 1,134.60 in intraday today.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."